tiprankstipranks
Trending News
More News >
Fine Foods & Pharmaceuticals N.T.M. SpA (IT:FF)
:FF
Italy Market

Fine Foods & Pharmaceuticals N.T.M. SpA (FF) Stock Statistics & Valuation Metrics

Compare
6 Followers

Total Valuation

Fine Foods & Pharmaceuticals N.T.M. SpA has a market cap or net worth of €186.74M. The enterprise value is €218.93M.
Market Cap€186.74M
Enterprise Value€218.93M

Share Statistics

Fine Foods & Pharmaceuticals N.T.M. SpA has 22,060,125 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,060,125
Owned by Insiders
Owned by Institutions

Financial Efficiency

Fine Foods & Pharmaceuticals N.T.M. SpA’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.30%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.30%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee312.90K
Profits Per Employee10.47K
Employee Count779
Asset Turnover1.00
Inventory Turnover4.45

Valuation Ratios

The current PE Ratio of Fine Foods & Pharmaceuticals N.T.M. SpA is 23.50. Fine Foods & Pharmaceuticals N.T.M. SpA’s PEG ratio is -0.07.
PE Ratio23.50
PS Ratio0.00
PB Ratio1.45
Price to Fair Value1.45
Price to FCF17.24
Price to Operating Cash Flow4.18
PEG Ratio-0.07

Income Statement

In the last 12 months, Fine Foods & Pharmaceuticals N.T.M. SpA had revenue of 243.75M and earned 8.16M in profits. Earnings per share was 0.32.
Revenue243.75M
Gross Profit101.83M
Operating Income14.64M
Pretax Income11.83M
Net Income8.16M
EBITDA30.90M
Earnings Per Share (EPS)0.32

Cash Flow

In the last 12 months, operating cash flow was 45.85M and capital expenditures -34.73M, giving a free cash flow of 11.12M billion.
Operating Cash Flow45.85M
Free Cash Flow11.12M
Free Cash Flow per Share0.50

Dividends & Yields

Fine Foods & Pharmaceuticals N.T.M. SpA pays an annual dividend of €0.259, resulting in a dividend yield of 1.57%
Dividend Per Share€0.259
Dividend Yield1.57%
Payout Ratio77.54%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.05
52-Week Price Change-8.07%
50-Day Moving Average6.87
200-Day Moving Average7.57
Relative Strength Index (RSI)63.00
Average Volume (3m)6.77K

Important Dates

Fine Foods & Pharmaceuticals N.T.M. SpA upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateApr 28, 2025

Financial Position

Fine Foods & Pharmaceuticals N.T.M. SpA as a current ratio of 1.36, with Debt / Equity ratio of 41.29%
Current Ratio1.36
Quick Ratio0.91
Debt to Market Cap0.28
Net Debt to EBITDA1.14
Interest Coverage Ratio4.44

Taxes

In the past 12 months, Fine Foods & Pharmaceuticals N.T.M. SpA has paid 3.68M in taxes.
Income Tax3.68M
Effective Tax Rate0.31

Enterprise Valuation

Fine Foods & Pharmaceuticals N.T.M. SpA EV to EBITDA ratio is 7.35, with an EV/FCF ratio of 20.41.
EV to Sales0.93
EV to EBITDA7.35
EV to Free Cash Flow20.41
EV to Operating Cash Flow4.95

Balance Sheet

Fine Foods & Pharmaceuticals N.T.M. SpA has €19.21M in cash and marketable securities with ― in debt, giving a net cash position of €35.32M billion.
Cash & Marketable Securities€19.21M
Total Debt
Net Cash€35.32M
Net Cash Per Share€1.60
Tangible Book Value Per Share€4.66

Margins

Gross margin is 34.82%, with operating margin of 6.01%, and net profit margin of 3.35%.
Gross Margin34.82%
Operating Margin6.01%
Pretax Margin4.85%
Net Profit Margin3.35%
EBITDA Margin12.68%
EBIT Margin6.21%

Analyst Forecast

The average price target for Fine Foods & Pharmaceuticals N.T.M. SpA is €11.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€11.50
Price Target Upside50.52% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-3.20%
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score64
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis